Siltuximab is an anti-IL-6 (interleukin-6) monoclonal antibody, and shows antitumor activity. Siltuximab can be used in Multicentric Castlemans Disease (MCD) and COVID-19 research.
Purity:
99.5%
CAS Number:
[541502-14-1]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted